Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ETHA vs GSK✓SelectedUSD · GSKETHA vs GSK performance historyLatest closeAs of-3.34%11/13
Stock and ETF performance explorer

ETHA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-38.7%
GSK return
+9.8%
Excess return
-48.5%
Maximum drawdown
-54.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.3%+0.5%-3.9%-3.3%
7D-12.5%+1.1%-13.7%-12.6%
30D-19.8%+6.3%-26.1%-20.0%
3M+3.1%+1.8%+1.3%+3.0%
6M-13.8%+1.7%-15.4%-14.0%
YTD-34.6%+6.5%-41.1%-36.5%
1Y-38.7%+9.5%-48.2%-41.8%
All-38.7%+9.8%-48.5%-41.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling